TABLETS INTENDED FOR TREATING CANCER PATIENTS, METHOD FOR THEIR MANUFACTURE, AND METHOD FOR TREATING CANCER PATIENTS

TABLETS INTENDED FOR TREATING CANCER PATIENTS, METHOD FOR THEIR MANUFACTURE, AND METHOD FOR TREATING CANCER PATIENTS

The tablets intended for treating cancer patients contain alkaloids of aconite, the acceptable carrier, and the lubricant. The effective dose of aconite alkaloids amounts to 0.0125-0.0375 mg. The method for manufacturing the tablets provides in assaying the total alkaloid content in aconite tincture...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: AKSIONOV HENNADII MYKOLAIOVYCH, SOBETSKY VOLODYMYR VITALIIOVYCH
Format: Patent
Sprache:eng
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator AKSIONOV HENNADII MYKOLAIOVYCH
SOBETSKY VOLODYMYR VITALIIOVYCH
description The tablets intended for treating cancer patients contain alkaloids of aconite, the acceptable carrier, and the lubricant. The effective dose of aconite alkaloids amounts to 0.0125-0.0375 mg. The method for manufacturing the tablets provides in assaying the total alkaloid content in aconite tincture followed by treating the suitable carrier. The amount of the carrier is calculated accounting for alkaloid content of 0.0125-0.0375 mg per one tablet. The carrier containing aconite alkaloids is dried and granulated. The granules are then coated with the suitable lubricant and compressed. Then method for treating cancer patients provides for prescribing 0.5-2 tablets.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_UA55302C2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>UA55302C2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_UA55302C23</originalsourceid><addsrcrecordid>eNrjZCgJcXTycQ0JVvD0C3H1c3F1UXDzD1IICXJ1DPH0c1dwdvRzdg1SCADyXP1CgnUUfF1DPPyhijxcPYMUfB39Qt0cnUNCg1x1FBz9XFBU4DCGh4E1LTGnOJUXSnMzyLm5hjh76KYW5MenFhckJqfmpZbEhzqamhobGDkbGRNUAAA-4Tdc</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>TABLETS INTENDED FOR TREATING CANCER PATIENTS, METHOD FOR THEIR MANUFACTURE, AND METHOD FOR TREATING CANCER PATIENTS</title><source>esp@cenet</source><creator>AKSIONOV HENNADII MYKOLAIOVYCH ; SOBETSKY VOLODYMYR VITALIIOVYCH</creator><creatorcontrib>AKSIONOV HENNADII MYKOLAIOVYCH ; SOBETSKY VOLODYMYR VITALIIOVYCH</creatorcontrib><description>The tablets intended for treating cancer patients contain alkaloids of aconite, the acceptable carrier, and the lubricant. The effective dose of aconite alkaloids amounts to 0.0125-0.0375 mg. The method for manufacturing the tablets provides in assaying the total alkaloid content in aconite tincture followed by treating the suitable carrier. The amount of the carrier is calculated accounting for alkaloid content of 0.0125-0.0375 mg per one tablet. The carrier containing aconite alkaloids is dried and granulated. The granules are then coated with the suitable lubricant and compressed. Then method for treating cancer patients provides for prescribing 0.5-2 tablets.</description><edition>7</edition><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2005</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20051017&amp;DB=EPODOC&amp;CC=UA&amp;NR=55302C2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,777,882,25545,76296</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20051017&amp;DB=EPODOC&amp;CC=UA&amp;NR=55302C2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>AKSIONOV HENNADII MYKOLAIOVYCH</creatorcontrib><creatorcontrib>SOBETSKY VOLODYMYR VITALIIOVYCH</creatorcontrib><title>TABLETS INTENDED FOR TREATING CANCER PATIENTS, METHOD FOR THEIR MANUFACTURE, AND METHOD FOR TREATING CANCER PATIENTS</title><description>The tablets intended for treating cancer patients contain alkaloids of aconite, the acceptable carrier, and the lubricant. The effective dose of aconite alkaloids amounts to 0.0125-0.0375 mg. The method for manufacturing the tablets provides in assaying the total alkaloid content in aconite tincture followed by treating the suitable carrier. The amount of the carrier is calculated accounting for alkaloid content of 0.0125-0.0375 mg per one tablet. The carrier containing aconite alkaloids is dried and granulated. The granules are then coated with the suitable lubricant and compressed. Then method for treating cancer patients provides for prescribing 0.5-2 tablets.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2005</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZCgJcXTycQ0JVvD0C3H1c3F1UXDzD1IICXJ1DPH0c1dwdvRzdg1SCADyXP1CgnUUfF1DPPyhijxcPYMUfB39Qt0cnUNCg1x1FBz9XFBU4DCGh4E1LTGnOJUXSnMzyLm5hjh76KYW5MenFhckJqfmpZbEhzqamhobGDkbGRNUAAA-4Tdc</recordid><startdate>20051017</startdate><enddate>20051017</enddate><creator>AKSIONOV HENNADII MYKOLAIOVYCH</creator><creator>SOBETSKY VOLODYMYR VITALIIOVYCH</creator><scope>EVB</scope></search><sort><creationdate>20051017</creationdate><title>TABLETS INTENDED FOR TREATING CANCER PATIENTS, METHOD FOR THEIR MANUFACTURE, AND METHOD FOR TREATING CANCER PATIENTS</title><author>AKSIONOV HENNADII MYKOLAIOVYCH ; SOBETSKY VOLODYMYR VITALIIOVYCH</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_UA55302C23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2005</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>AKSIONOV HENNADII MYKOLAIOVYCH</creatorcontrib><creatorcontrib>SOBETSKY VOLODYMYR VITALIIOVYCH</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>AKSIONOV HENNADII MYKOLAIOVYCH</au><au>SOBETSKY VOLODYMYR VITALIIOVYCH</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>TABLETS INTENDED FOR TREATING CANCER PATIENTS, METHOD FOR THEIR MANUFACTURE, AND METHOD FOR TREATING CANCER PATIENTS</title><date>2005-10-17</date><risdate>2005</risdate><abstract>The tablets intended for treating cancer patients contain alkaloids of aconite, the acceptable carrier, and the lubricant. The effective dose of aconite alkaloids amounts to 0.0125-0.0375 mg. The method for manufacturing the tablets provides in assaying the total alkaloid content in aconite tincture followed by treating the suitable carrier. The amount of the carrier is calculated accounting for alkaloid content of 0.0125-0.0375 mg per one tablet. The carrier containing aconite alkaloids is dried and granulated. The granules are then coated with the suitable lubricant and compressed. Then method for treating cancer patients provides for prescribing 0.5-2 tablets.</abstract><edition>7</edition><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_UA55302C2
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title TABLETS INTENDED FOR TREATING CANCER PATIENTS, METHOD FOR THEIR MANUFACTURE, AND METHOD FOR TREATING CANCER PATIENTS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T20%3A43%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=AKSIONOV%20HENNADII%20MYKOLAIOVYCH&rft.date=2005-10-17&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUA55302C2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true